Free Trial
NASDAQ:PLSE

Pulse Biosciences (PLSE) Stock Price, News & Analysis

Pulse Biosciences logo
$17.68 +1.56 (+9.68%)
(As of 11/22/2024 ET)

About Pulse Biosciences Stock (NASDAQ:PLSE)

Key Stats

Today's Range
$16.05
$17.71
50-Day Range
$14.56
$20.39
52-Week Range
$6.59
$22.69
Volume
138,427 shs
Average Volume
197,097 shs
Market Capitalization
$1.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Pulse Biosciences Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
32nd Percentile Overall Score

PLSE MarketRank™: 

Pulse Biosciences scored higher than 32% of companies evaluated by MarketBeat, and ranked 751st out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Pulse Biosciences.

  • Percentage of Shares Shorted

    14.85% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 15.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently decreased by 7.64%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Pulse Biosciences does not currently pay a dividend.

  • Dividend Growth

    Pulse Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    14.85% of the float of Pulse Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Pulse Biosciences has a short interest ratio ("days to cover") of 15.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Pulse Biosciences has recently decreased by 7.64%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Pulse Biosciences has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Pulse Biosciences this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for PLSE on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Pulse Biosciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pulse Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    71.50% of the stock of Pulse Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.95% of the stock of Pulse Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Pulse Biosciences' insider trading history.
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

I hate to say I told you so
Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…
Pulse Biosciences Inc PLSE
Pulse Biosciences Reports Q3 2024 Financials and Developments
See More Headlines

PLSE Stock Analysis - Frequently Asked Questions

Pulse Biosciences' stock was trading at $12.24 at the beginning of the year. Since then, PLSE shares have increased by 44.4% and is now trading at $17.68.
View the best growth stocks for 2024 here
.

Pulse Biosciences, Inc. (NASDAQ:PLSE) posted its quarterly earnings results on Wednesday, October, 30th. The company reported ($0.21) earnings per share for the quarter.

Pulse Biosciences (PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Top institutional investors of Pulse Biosciences include State Street Corp (0.75%), Geode Capital Management LLC (0.74%), Charles Schwab Investment Management Inc. (0.24%) and Westside Investment Management Inc. (0.09%). Insiders that own company stock include Mitchell E Levinson, Kevin Patrick Danahy and Burke Thomas Barrett.
View institutional ownership trends
.

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pulse Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and Jabil (JBL).

Company Calendar

Last Earnings
10/30/2024
Today
11/22/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/27/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
140
Year Founded
N/A

Profitability

Net Income
$-42,210,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$700,000.00
Book Value
$1.29 per share

Miscellaneous

Free Float
17,532,000
Market Cap
$1.09 billion
Optionable
Optionable
Beta
1.75
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:PLSE) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners